Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "SigTuple"

4 News Found

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
Startup | October 03, 2023

SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance

SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
Diagnostic Center | April 17, 2023

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices

The blood test market worldwide is today around $75-80 billion

Thyrocare adopts SigTuple’s AI100 to make quality diagnostics accessible
Digitisation | February 22, 2023

Thyrocare adopts SigTuple’s AI100 to make quality diagnostics accessible

In a bid to better leverage its clinical expertise and drive quality reporting across its centres, Thyrocare has added SigTuple’s AI100 to automate the microscopic review in its laboratories

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
Healthcare | September 23, 2022

KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India

Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune

Latest Stories

Philips Respironics agrees to pay $1.1 billion settlement after CPAP machine recall

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data

Lilly posts Q1 2024 revenue up 26% at US$ 8.77 billion

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
Vinod Paremal President & MD, Evonik, India Region

Packaging